A descriptive study of the variation in baseline levels of anti-endotoxin core antibodies between US and UK populations.
- Published in:
- Innate Immunity, 2004, v. 10, n. 3, p. 195, doi. 10.1177/09680519040100030601
- By:
- Publication type:
- Article
Works matching IS 17534259 AND DT 2004 AND VI 10 AND IP 3
Results: 6
1
2
LPS binding protein does not participate in the pharmacokinetics of E5564.
- Published in:
- Innate Immunity, 2004, v. 10, n. 3, p. 185, doi. 10.1177/09680519040100030501
- By:
- Publication type:
- Article
3
Bacterial endotoxin modifies heat shock factor-1 activity in RAW 264.7 cells: implications for TNF-α regulation during exposure to febrile range temperatures.
- Published in:
- Innate Immunity, 2004, v. 10, n. 3, p. 175, doi. 10.1177/09680519040100030401
- By:
- Publication type:
- Article
4
Review: D-Galactosamine lethality model: scope and limitations.
- Published in:
- Innate Immunity, 2004, v. 10, n. 3, p. 147, doi. 10.1177/09680519040100030201
- By:
- Publication type:
- Article
5
C-reactive protein: a predominant LPS-binding acute phase protein responsive to Pseudomonas infection.
- Published in:
- Innate Immunity, 2004, v. 10, n. 3, p. 163, doi. 10.1177/09680519040100030301
- By:
- Publication type:
- Article
6
Editorial.
- Published in:
- Innate Immunity, 2004, v. 10, n. 3, p. 146, doi. 10.1177/09680519040100030101
- By:
- Publication type:
- Article